Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Patients facing advanced prostate cancer or living with the challenges of metastatic prostate cancer often feel overwhelmed by the number of therapies, consultations, and decisions
Retatrutide may become an option in the future if: Its approved by the MHRA and recommended by NICE, which is likely several years away You havent responded well to existing GLP-1 medications, and a triple agonist offers a different approach worth trying The Phase 3 safety data on heart rate, irregular heartbeats, and dysesthesia are reassuring once its complete For most people in the UK, the choice now is between Wegovy and Mounjaro, supported by a structured weight management service
For additional information, contact your insurance company
The effect was most pronounced during the first half of the night, when endogenous GH secretion is naturally highest
Diabetes2000 Sep;49(9):1434-42
US$ 28.06
US$ 20.06
US$ 28.34
US$ 22.47
US$ 28.60
